Snabbit Tops Asia Startup Funding Week with $56M Round

Context Asia’s venture scene stayed active this week, spreading $159 million across fintech, biotech, gaming, logistics and deep‑tech. Investors continued to back both consumer platforms and the underlying infrastructure that powers digital services.

Key Facts - Snabbit, an on‑demand home‑services platform based in India, closed a $56 million round. The round was co‑led by Susquehanna Venture Capital, Mirae Asset Venture Investments and Bertelsmann India Investments, with existing backers Nexus Venture Partners and Lightspeed also participating. - Shanghai‑based Vivacta Biotechnology raised more than $50 million across its Series A and A+ rounds, led by Loyal Valley Capital and Decheng Capital. The capital will fund clinical development and global market entry. - Bengaluru’s trading platform Sahi secured $33 million in Series B funding from Accel, pushing its valuation to roughly $200 million and earmarking the money for technology upgrades and user‑base expansion. - Additional notable deals included Metasports Interactive’s $20 million raise for its cricket game Hitwicket, Battery Smart’s $15 million debt financing to grow its EV‑battery‑swap network, and Oolka’s $14 million Series A for AI‑driven credit tools.

What It Means Snabbit’s $56 million raise underscores continued confidence in consumer‑facing services that aggregate fragmented home‑service markets. The participation of both global and local investors signals belief that the Indian market can sustain rapid scaling. Vivacta’s biotech funding highlights a parallel surge in health‑tech capital, where investors are willing to back costly clinical pipelines for long‑term payoff. The size of the round places Vivacta among the few Asian biotech firms crossing the $50 million threshold this year. Sahi’s $33 million injection reflects a broader appetite for fintech infrastructure that enables retail trading. By valuing the company at $200 million, investors signal that trading platforms remain a growth engine despite market volatility. Overall, the week’s mix of consumer, biotech and fintech deals suggests a balanced risk appetite: capital flows to both visible user‑growth ventures and the less glamorous, but essential, technology layers that support them. The pattern points to a maturing ecosystem where investors are building the scaffolding for the next wave of digital expansion.

Looking ahead, monitor whether the funding momentum extends into Q3, especially in AI‑driven platforms and deep‑tech sectors that could reshape Asia’s startup landscape.